Skip to content
Biofrontera Inc. logo

Biofrontera Inc. (BFRI) Q1 2024 Earnings

BFRI·Reported May 15, 2024·After market close

Biofrontera Inc. reported Q1 2024 revenue of $7.9M, missed analyst consensus of $10.9M by $3.0M. Diluted EPS came in at $-1.85, missed the $-1.63 consensus by $0.22.

Revenue
$7.9Mmissed by $3.0M
Consensus: $10.9M
Diluted EPS
$-1.85missed by $0.22
Consensus: $-1.63
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q1 2024

Q1 2024 Earnings FAQ

Common questions about Biofrontera Inc.'s Q1 2024 earnings report.

Biofrontera Inc. (BFRI) reported Q1 2024 earnings on May 15, 2024 after market close.

Biofrontera Inc. reported revenue of $7.9M and diluted EPS of $-1.85 for Q1 2024.

Revenue missed the consensus estimate of $10.9M by $3.0M. EPS missed the consensus estimate of $-1.63 by $0.22.

You can read the 10-Q periodic report (0001493152-24-019878) directly on SEC EDGAR. The filing index links above go to sec.gov.